Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
AI and deep learning can extract molecular markets of breast cancer from tissue morphology and assist pathologists in a mass-scale molecular profiling, according to new research published in JAMA Network Open.
Deep reinforcement learning enabled by AI can help physicians figure out whether opioids would truly be better than other interventions for patients suffering pain in intensive care units.
The venture arm of 32-hospital UnityPoint Health is partnering with VIDA Diagnostics, investing $1 million to fine-tune and broaden the use of VIDA’s AI software for flagging signs of trouble in lung images.
The power of AI in medicine has come to light in Alabama, where an 11-year-old in medical peril had the good fortune to have a dad who’s an AI-specialized computer programmer working in healthcare.
Researchers and data scientists at IBM have developed three novel algorithms aimed at uncovering the underlying biological processes that cause tumors to form and grow.
Walgreens store associates and managers across the U.S. will soon be equipped with small, AI-powered devices that will allow them to remain “heads-up and hands-free” while communicating among themselves to help customers.
Compared with standard statistical reviews of process-control charts, AI analysis of data routinely captured by hospitals monitoring handwashing compliance can provide highly targeted and actionable feedback to individual healthcare workers.
